About
Procter & Gamble Hygiene and Health Care Ltd
Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. The Company's products are sold through retail operations
including mass merchandisers, grocery stores, membership club stores, drug stores, department stores and high frequency stores. The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, apart from third party manufacturing locations spread across India..
The company was incorporated on 20th July 1964 at Mumbai. The Company's saga dates way back to the establishment of Richardson Hindustan Limited (RHL), which obtained an Industrial License to undertake manufacture of Menthol and de mentholised peppermint oil and VICKS range of products such as Vicks VapoRub, Vicks Cough Drops and Vicks Inhaler. The premier product of the company, Vicks Action 500 was launched in the year 1979 and in 1984; an Ayurvedic Research Laboratory was gone to live. In October of the year 1985, RHL became an affiliate of The Procter & Gamble Company, USA. In 1989, Procter & Gamble India (after change in name from RHL) launched Whisper, the breakthrough technology sanitary napkin at first time. In 1991, the company had launched Ariel detergent and also in the same year the Mandideep (Bhopal) Factory started its operations. During the year 1993, P&G had divested the Detergents business to Procter & Gamble Home Products. Goa Honda Factory of the company was started its operations in the year 1996 for manufacture the Vicks Vaporub. After two years, in 1998, Goa Kundiam Factory started its operations for manufacture the Whisper pads.
During the year 1999, the company changed its name from Procter & Gamble India Limited to Procter & Gamble Hygiene and Health Care Limited and also in the identical year, Mediker Shampoo business was divested to Marico Industries. In 2000, the company had introduced Whisper Ultra, Vicks Plus Medicated Lozenges and re launched Vicks Action 500+. To make Indian consumers affordable, the company had reduced its prices on Whisper in the year 2001. P&G had launched New Improved Vicks VapoRub in the year 2002, India's number one Cold Rub that provides multi-symptom relief from the six symptoms of a child's cold and also in the same year launched Vicks Action500+ Night tablets. Vicks Formula 44 Cough Syrup, which was introduced by the company in the year of 2003 to provide safe, effective and long lasting relief for up to eight hours from tough persistent coughs due to colds. P&G had commenced test marketing of economically priced and competitively superior performing, Whisper Choice pads in the southern states of Karnataka, Tamil Nadu, Andhra Pradesh and Kerala during the year 2004. After a year, in 2005, the company had launched Whisper Choice National in Indian market and also acquired Gillette globally. Building the brand equity of Whisper and what's more, has won the Bronze Lion Award at the Cannes International Advertising Festival 2006.
During 2007-08, the company entered into a Public Private Partnership with the National Rural Health Mission, Rajasthan, to provide women in Rajasthan with a better option of sanitary protection and by consequence, a healthier, more productive life.
On 16 March 2016, Procter & Gamble Hygiene and Health Care announced that the Delhi High Court has granted interim injunction suspending Government notification prohibiting the manufacture for sale, sale and distribution for Fixed Dose Combination drugs (Paracetamol + Phenylephrine + Caffeine) till the next hearing. Accordingly, the company will resume manufacture and sale of Vicks Action 500 Extra.
On 1 April 2017, promoter shareholder of Procter & Gamble Hygiene and Health Care, viz., Rosemount LLC transferred 10.88 lakh shares (3.35% of shareholding) held in the company to another promoter group company, Procter & Gamble Overseas India B.V., the Netherlands.
The Board of Directors of Procter & Gamble Hygiene and Health Care at its meeting held on 5 May 2017 declared special interim dividend of Rs 362 per share from accumulated surplus from profits of earlier years and the current year. The dividend demonstrates the company's intent to reward shareholders for strong results in a competitive market environment.
During the Financial Year 2017-18, Company launched Vicks BabyRub, specially developed for babies and gentle on their skin.
Procter & Gamble Hygiene and Health Care Ltd
Chairman Speech
Dear Shareholders,
I would like to take this opportunity to share with you the overall
performance of the Company in 2022-2023.
Despite a challenging macro-economic environment marked by significant
operating and cost headwinds, the Company delivered a resilient finish to the fiscal year.
During the year, the Company delivered revenue from operations of Rs3918 crore, flat
versus year ago, with a one-time non-operating income and the pandemic- linked demand
surge in the healthcare portfolio in the base period. Operationally sales were up 3% for
the fiscal. Further, the Company reported Profit After Tax (PAT) of Rs 678 crores, up 18%
versus year ago including one-time tax impacts. Excluding these one-time impacts, Profit
After Tax (PAT) is up 10% operationally.
This encouraging growth was driven by premiumization and productivity
interventions, as the Company continued to make sequential progress in profit growth,
despite macro-economic challenges, and a muted growth in the healthcare category in the
first three quarters of the year owing to the pandemic linked demand surge in the base
period.
The Company continued to raise the bar on superiority, innovation, and
industry-leading practices. The driving force has been the focused execution of its
integrated growth strategy - a focus on daily use categories where performance drives
brand choice, superiority (of product, package, communication, go-to-market execution, and
value), productivity, constructive disruption, and an agile and accountable organization
structure and culture - which enabled a sustainable, balanced growth and value creation.
The feminine care and healthcare brands, Whisper, and Vicks
respectively, continue to grow behind a strong product portfolio, superior consumer
communication and a continuous stream of product innovations like Whisper Hygiene Comfort,
Whisper Choice Nights, Vicks ZzzQuil, Vicks Roll-On Inhaler and Vicks Xtra Strong.
Whisper continued its journey of raising awareness regarding
menstruation, with the fourth edition of its long running #KeepGirlsInSchool (KGIS)
movement, with the aim of educating mothers on the biology of periods to help them educate
their daughters.
Whisper also continues to scale up the ‘Whisper Menstrual Health
& Hygiene Program', educating over 2 crore girls on puberty and hygiene over last
two years. To date, Whisper has educated over 10 crore girls and mothers. This year,
Whisper India also partnered with UNESCO India to introduce teaching-learning modules,
addressing the challenges related to menstrual health and hygiene management, including in
relation to disability, gender, teachers and educators, young adults, and nutrition.
The Company's flagship CSR program, P&G Shiksha, is a
360-degree educational intervention that addresses three critical barriers to achieving
universal education - access to education infrastructure, gender inequality in access to
education and gap in learning.
As we enter the new fiscal year, the Company is well positioned to
sustain and improve its performance with a resilient and empowered workforce, leverage
opportunities with agility, address challenges and overcome the risks. While short to
medium term challenges exist owing to a weak global economic outlook, the long-term
outlook for the FMCG sector remains positive. We will continue to focus on our integrated
growth strategy which has consistently enabled us to deliver sustained and balanced
growth.
L. V. Vaidyanathan
Managing Director
  Â
Procter & Gamble Hygiene and Health Care Ltd
Company History
Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. The Company's products are sold through retail operations
including mass merchandisers, grocery stores, membership club stores, drug stores, department stores and high frequency stores. The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, apart from third party manufacturing locations spread across India..
The company was incorporated on 20th July 1964 at Mumbai. The Company's saga dates way back to the establishment of Richardson Hindustan Limited (RHL), which obtained an Industrial License to undertake manufacture of Menthol and de mentholised peppermint oil and VICKS range of products such as Vicks VapoRub, Vicks Cough Drops and Vicks Inhaler. The premier product of the company, Vicks Action 500 was launched in the year 1979 and in 1984; an Ayurvedic Research Laboratory was gone to live. In October of the year 1985, RHL became an affiliate of The Procter & Gamble Company, USA. In 1989, Procter & Gamble India (after change in name from RHL) launched Whisper, the breakthrough technology sanitary napkin at first time. In 1991, the company had launched Ariel detergent and also in the same year the Mandideep (Bhopal) Factory started its operations. During the year 1993, P&G had divested the Detergents business to Procter & Gamble Home Products. Goa Honda Factory of the company was started its operations in the year 1996 for manufacture the Vicks Vaporub. After two years, in 1998, Goa Kundiam Factory started its operations for manufacture the Whisper pads.
During the year 1999, the company changed its name from Procter & Gamble India Limited to Procter & Gamble Hygiene and Health Care Limited and also in the identical year, Mediker Shampoo business was divested to Marico Industries. In 2000, the company had introduced Whisper Ultra, Vicks Plus Medicated Lozenges and re launched Vicks Action 500+. To make Indian consumers affordable, the company had reduced its prices on Whisper in the year 2001. P&G had launched New Improved Vicks VapoRub in the year 2002, India's number one Cold Rub that provides multi-symptom relief from the six symptoms of a child's cold and also in the same year launched Vicks Action500+ Night tablets. Vicks Formula 44 Cough Syrup, which was introduced by the company in the year of 2003 to provide safe, effective and long lasting relief for up to eight hours from tough persistent coughs due to colds. P&G had commenced test marketing of economically priced and competitively superior performing, Whisper Choice pads in the southern states of Karnataka, Tamil Nadu, Andhra Pradesh and Kerala during the year 2004. After a year, in 2005, the company had launched Whisper Choice National in Indian market and also acquired Gillette globally. Building the brand equity of Whisper and what's more, has won the Bronze Lion Award at the Cannes International Advertising Festival 2006.
During 2007-08, the company entered into a Public Private Partnership with the National Rural Health Mission, Rajasthan, to provide women in Rajasthan with a better option of sanitary protection and by consequence, a healthier, more productive life.
On 16 March 2016, Procter & Gamble Hygiene and Health Care announced that the Delhi High Court has granted interim injunction suspending Government notification prohibiting the manufacture for sale, sale and distribution for Fixed Dose Combination drugs (Paracetamol + Phenylephrine + Caffeine) till the next hearing. Accordingly, the company will resume manufacture and sale of Vicks Action 500 Extra.
On 1 April 2017, promoter shareholder of Procter & Gamble Hygiene and Health Care, viz., Rosemount LLC transferred 10.88 lakh shares (3.35% of shareholding) held in the company to another promoter group company, Procter & Gamble Overseas India B.V., the Netherlands.
The Board of Directors of Procter & Gamble Hygiene and Health Care at its meeting held on 5 May 2017 declared special interim dividend of Rs 362 per share from accumulated surplus from profits of earlier years and the current year. The dividend demonstrates the company's intent to reward shareholders for strong results in a competitive market environment.
During the Financial Year 2017-18, Company launched Vicks BabyRub, specially developed for babies and gentle on their skin.
Procter & Gamble Hygiene and Health Care Ltd
Directors Reports
Procter & Gamble Hygiene and Health Care Ltd
Company Background
| Incorporation Year | 1964 |
| Registered Office | P & G Plaza Chakala,Cardinal Gracias Rd Andheri(E)
Mumbai,Maharashtra-400099 |
| Telephone | 91-22-28266000,Managing Director |
| Fax | 91-22-28267303 |
Chittranjan DuaL. V. Vaidyanathan| Company Secretary | Ghanashyam Hedge |
| Auditor | Kalyaniwalla & Mistry LLP |
| Face Value | 10 |
| Market Lot | 1 |
| Listing | BSE,MSEI ,NSE, |
| Registrar | Link Intime India Pvt Ltd
C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083 |
Procter & Gamble Hygiene and Health Care Ltd
Company Management
| Director Name | Director Designation | Year |
|---|
| A K Gupta | Independent Director | 2022 |
| Sonali Dhawan | Director | 2022 |
| Karthik Natarajan | Director | 2022 |
| Pramod Agarwal | Director | 2022 |
| Gagan Sawhney | Director | 2022 |
| MEENA GANESH | Independent Director | 2022 |
| Ghanashyam Hedge | Executive Director & Secretary | 2022 |
| Chittranjan Dua | Chairman & Independent Directo | 2022 |
| Krishnamurthy Narayanan Iyer | Independent Director | 2022 |
| L. V. Vaidyanathan | Managing Director | 2022 |
| Gurcharan Das. | Independent Director | 2022 |
| Ashima Goyal | Non Executive Director | 2022 |
Procter & Gamble Hygiene and Health Care Ltd
Listing Information
| Listing Information |
|---|
| BSE_500 |
| BSE_FMCG |
| BSE_200 |
| BSEDOLLEX |
| CNX500 |
| BSEMID |
| CNX_MNC |
| CNX_FMCG |
| BSEALLCAP |
| LMI250 |
| BSE100LTMC |
| NFTYLM250 |
| NFTYMC150 |
| NFTYMSC400 |
| NFTY100ESG |
| NF500M5025 |
| NFTYTOTMKT |
Procter & Gamble Hygiene and Health Care Ltd
Finished Product
| Product Name | Unit | Installed
Capacity | Production
Quantity | Sales
Quantity | Sales
Value |
|---|
| Others | NA | 0 | 0 | 0 | 2672.23 |
| Ointment & Creams | MT | 0 | 0 | 0 | 768.18 |
| Cough Drops | MT | 0 | 0 | 0 | 402.38 |
| Tablets | No | 0 | 0 | 0 | 75.11 |
| Peppermint Oil-Demontholised | MT | 0 | 0 | 0 | 0 |
| Cosmetics/Toilet Preparations | KL | 0 | 0 | 0 | 0 |
| Cosmetics/Toilet Preparations | MT | 0 | 0 | 0 | 0 |
| Pers.prod/Toilet Preparat.-Tra | NA | 0 | 0 | 0 | 0 |
| Powders | MT | 0 | 0 | 0 | 0 |
| Soaps & Detergents | MT | 0 | 0 | 0 | 0 |
| Soaps & Detergents | Pcs | 0 | 0 | 0 | 0 |
| Liquids | KL | 0 | 0 | 0 | 0 |
| Other Operating Revenue | NA | 0 | 0 | 0 | 0 |
| Scrap Sales | NA | 0 | 0 | 0 | 0 |
| License Fees | NA | 0 | 0 | 0 | 0 |
| Menthol | MT | 0 | 0 | 0 | 0 |